How do oncologists deal with incidental abnormalities on whole‐body fluorine‐18 fluorodeoxyglucose PET/CT?

Combined positron emission tomography (PET)/computed tomography (CT) using fluorine‐18 fluorodeoxyglucose (FDG) is an exciting technique for cancer evaluation, but false‐positive results are a recognized limitation. The aim of the study was to evaluate how oncologists deal with focal extrathyroidal FDG abnormalities considered by imaging specialists to be unrelated to the referral indication.

[1]  T. Wiggers,et al.  Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  A. Pecking,et al.  Incidental colonic focal lesions detected by FDG PET/CT. , 2005, AJR. American journal of roentgenology.

[3]  R. Wahl,et al.  Detection of unexpected additional primary malignancies with PET/CT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  Z. Keidar,et al.  PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  A. Alavi,et al.  Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy. , 2005, Clinical nuclear medicine.

[6]  T. Muto,et al.  Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer , 2003, International Journal of Clinical Oncology.

[7]  M. Spieth,et al.  A tabulated summary of the FDG PET literature. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  K. Hemminki,et al.  Second primary neoplasms in 633,964 cancer patients in Sweden, 1958–1996 , 2001, International journal of cancer.

[9]  D Delbeke,et al.  Prospective investigation of positron emission tomography in lung nodules. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Ludwig G. Strauss,et al.  Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients , 1996, European Journal of Nuclear Medicine.

[11]  M Schwaiger,et al.  Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. P. Spencer,et al.  Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  R L Wahl,et al.  Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.